Sheng Fu, MD (@shengfumd) 's Twitter Profile
Sheng Fu, MD

@shengfumd

Advanced Heart Failure and Transplant Cardiologist.
@UofLHealth by way of @MUSChealth and @AHNtoday.

ID: 1095490470896128001

calendar_today13-02-2019 01:10:56

19 Tweet

165 Followers

232 Following

Benjamin Hibbert (@benhibbertmdphd) 's Twitter Profile Photo

Proud to announce the publication of CAPITAL DOREMI in NEJM - a comparison of milrinone and dobutamine in cardiogenic shock. Contrary to the hypothesis milrinone was not superior to dobutamine in this randomized double blind comparison. nejm.org/doi/full/10.10…

Proud to announce the publication of CAPITAL DOREMI in <a href="/NEJM/">NEJM</a> - a comparison of milrinone and dobutamine in cardiogenic shock. Contrary to the hypothesis milrinone was not superior to dobutamine in this randomized double blind comparison. nejm.org/doi/full/10.10…
Nature Medicine (@naturemedicine) 's Twitter Profile Photo

Read our News and Views by Ryan J Tedford MD and colleagues MUSC Health for an insightful discussion into SGLT-2 inhibitors for treatment of #heartfailure with preserved ejection fraction. nature.com/articles/s4159…

European Society of Cardiology (@escardio) 's Twitter Profile Photo

#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease. #ESCCongress

#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease.

#ESCCongress
John Mandrola, MD (@drjohnm) 's Twitter Profile Photo

My latest on Stop and Think There may be a BIG NEW development in cardiology. I describe it here. See what you think> johnmandrola.substack.com/p/big-changes-…

Ryan J Tedford MD (@ryantedfordmd) 's Twitter Profile Photo

Do you love hemodynamics & RHCs? Sheng Fu, MD Chakradhari Inampudi & I do too! BUT, hemodynamic evaluation of donor hearts may not be helpful. Abnormal hemos, particularly high filling pressures, did not correlate w/ post-transplant outcomes in our UNOS analysis. onlinejcf.com/article/S1071-…

Do you love hemodynamics &amp; RHCs? <a href="/ShengFuMD/">Sheng Fu, MD</a> <a href="/chakri0012/">Chakradhari Inampudi</a> &amp; I do too!  BUT, hemodynamic evaluation of donor hearts may not be helpful. Abnormal hemos, particularly high filling pressures, did not correlate w/ post-transplant outcomes in our UNOS analysis. onlinejcf.com/article/S1071-…